Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On December 27, 2024, our Sponsor paid an aggregate of $25,000, or approximately $0.017 per share,
for the purchase of 1,437,500 founder shares, par value $0.0001. Our Sponsor is an
accredited investor for purposes of Rule 501(a) of Regulation D of the Securities Act of 1933, as amended. Each of the equity
holders in our Sponsor are accredited investors under Rule 501(a) of Regulation D. The sole business of our Sponsor is to act as the Company’s sponsor in connection with this offering.
On May 30, 2025, we consummated our IPO of 5,000,000 Units, at $10.00 per Unit, generating gross
proceeds of $50,000,000. We granted the underwriter a 45-day option to purchase up
to an additional 750,000 Units at the IPO price to cover over-allotments. On May 29, 2025, the over-allotment option was exercised in part, and 595,000 Units, at $10.00 per Unit were sold, generating gross proceeds of $5,950,000. Meanwhile, 55,950 ordinary shares were issued to the underwriter at the closing of the IPO as representative
shares, and 55,950 representative shares will be issued as the deferred underwriting commission at
the consummation of a Business Combination. The securities sold in the IPO were sold
pursuant to a registration statement on Form S-1 (File No.: 333-286795). The registration statement became effective on May 28, 2025.
Simultaneously with the consummation of the closing of the IPO, we consummated a private
placement of an aggregate of 253,875 Units to the Sponsor at a price of $10.00 per Unit, generating gross proceeds of $2,538,750. The Private Units are identical to the Units sold in the IPO except that the holder
has agreed not to transfer, assign, or sell any of the Private Units or underlying
securities (except in limited circumstances, as described in the Registration Statement)
until the completion of the Company’s initial business combination. The sponsor was granted certain demand and piggy-back
registration rights in connection with the purchase of the Private Units. The issuance
was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
On May 30, 2025, a total of $56,089,875 of the
net proceeds from the IPO and the Private Placement were deposited in a trust account established for the benefit of the public shareholders.
For the nine months ended September 30, 2025, income earned on marketable securities held in Trust Account were $785,952. As of
September 30, 2025, the fair value of marketable securities held in Trust Account of $56,875,827.
Transaction costs of the IPO with the exercise of the over-allotment amounted to $1,308,056, consisting of $1,052,982 of underwriting commissions, which were paid in cash and $559,500 of underwriting commissions, which were paid in representative shares (55,950 ordinary shares), at the closing date of the IPO, respectively, and $255,074 of other offering costs.
Meanwhile, pursuant the underwriting agreement,
1.0% of the gross proceeds of the IPO, or $559,500, will be paid in cash, and 55,950 representative shares will be issued, both of which
as the deferred underwriting commission at the consummation of a Business Combination.
On July 13, 2025, the remaining unexercised over-allotment
option to purchase up to 155,000 Units at $10.00 per Unit were expired and 38,750 ordinary shares were forfeited along with the expiry
of the over-allotment option.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.